Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults

NCT01612000 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

341

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: PanBlok
BIOLOGICAL: rHA adjuvant

Sponsor

Protein Sciences Corporation